Article
CYP2C19 Genetic Variability, ADP-Induced Whole-Blood Platelet Aggregation, and Clopidogrel Response in an Exploratory Retrospective Cohort of Acute Ischemic Stroke.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis - 1 Jan 2026
Ravichandran Soumya, Phan Cattien, Meyer Dawn M, Eghbalnejadmofrad Amirmohammad, Akhavan-Sigari Amirhossein, Jazayeri Seyed Behnam, Batarseh Sanad, D'Souza Marissa, Hu Tiffany, Hailey Lovella, Agrawal Kunal, Modir Royya F, Hemmen Thomas, Meyer Brett C, Bavarsad Shahripour Reza
Abstract excerpt
BackgroundPatient response to clopidogrel varies due to CYP2C19 genetic polymorphisms. Impaired metabolism has been linked to an increased risk of recurrent ischemic events. The purpose of this study was to examine CYP2C19 phenotypes and the impact on ADP aggregation in whole blood platelet aggregometry (WBPA) in patients with acute ischemic stroke (AIS).MethodsPatients with AIS or transient ischemic attack (TIA)...
Read the complete abstract on PubMedTopics
- Humans
- Cytochrome P-450 CYP2C19
- Clopidogrel
